Multi-enzyme mimic Mn₃O₄@SiO₂ nanoparticles for efficient anti-inflammation therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oral Medicine

Background:

• Gingivitis prevalence necessitates advanced treatments due to high healthcare costs.
• Excessive reactive oxygen species (ROS) are key contributors to gingivitis and inflammation.
• Current gingivitis medications show limitations in efficacy and pathogen management.

Purpose of the Study:

• To design and prepare novel Mn3O4@SiO2 nanoparticles (NPs) for gingivitis treatment.
• To evaluate the antioxidant and anti-inflammatory capabilities of Mn3O4@SiO2 NPs.
• To assess the therapeutic potential of Mn3O4@SiO2 NPs in a gingivitis mouse model.

Main Methods:

• Synthesis of Mn3O4@SiO2 NPs using an in situ templating method.
• Evaluation of in vivo antioxidant removal capacity and TNF-α sequestration.
• Assessment of IL-1β down-regulation in a gingivitis mouse model.

Main Results:

• Mn3O4@SiO2 NPs exhibited over 2.5 times higher in vivo antioxidant removal than Mn3O4 NPs.
• A 3-fold increase in TNF-α sequestration efficacy was observed for Mn3O4@SiO2 NPs.
• Mn3O4@SiO2 NPs down-regulated IL-1β by 65% in the gingivitis mouse model.

Conclusions:

• Mesoporous SiO2-supported Mn3O4 NPs enhance ROS scavenging via increased surface area and dispersity.
• Mn3O4@SiO2 NPs demonstrate significant biosafety and therapeutic effects for gingivitis.
• These NPs represent a promising platform for treating gingivitis and other inflammatory diseases.